madrigalpharma.com
Global Rankeez rank — last updated 01 Aug 2026
Better than 99.4% of the 102,887,824 domains we track
Source breakdown
Rankeez combines several independent public rankings. Here's how madrigalpharma.com scores in each:
| Source | Rank |
|---|---|
| Tranco (research-grade ranking, resistant to manipulation) | #604,489 |
| Majestic Million (ranked by referring subnets) | #310,288 |
| DomCop / OpenPageRank | #1,963,057 |
| CommonCrawl (hyperlink graph) | #708,583 |
See how these sources are combined and cross-validated →
Ranking history
madrigalpharma.com's rank across 3 monthly snapshots. ▲ improved by 37,360,474 since 2026-06
| Month | Rank |
|---|---|
| 2026-06 | #37,947,378 |
| 2026-07 | #625,410 |
| 2026-08 | #586,904 |
JSON API
{
"madrigalpharma.com": 586904,
"history": {
"2026-06": 37947378,
"2026-07": 625410,
"2026-08": 586904
}
}
GET https://rankeez.com/api/madrigalpharma.com.json · see API docs →
More about madrigalpharma.com
madrigalpharma.com — page content & similar sites →
Madrigal Pharmaceuticals, Inc. (Nasdaq: MGDL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardi
madrigalpharma.com — full site profile →
WHOIS, tech stack and extended traffic history for madrigalpharma.com.